Showing results (141-150 of 251) with videos related to

Sort By:
Pageof 26
Deutsche Medizinische Wochenschrift (1946)|June 1, 1979
[Combined chemotherapy and radiotherapy of localized and metastasizing Ewing's sarcoma (author's transl)]S Seeber, E Siemers, K Höffken, et al.
Leukemia & Lymphoma|June 1, 1997
Recurrence of Hodgkin's disease after 10 or more years: late relapse or de-novo malignancy due to HLA-DPB1*0301-linked susceptibility?R Siebert, A Fosså, W Kaiser, et al.
Obstetrics and Gynecology International|February 20, 2010
Hypoxia-inducible factor-1 as a therapeutic target in endometrial cancer managementLaura M S Seeber, Ronald P Zweemer, René H M Verheijen, et al.
European Journal of Cancer (Oxford, England : 1990)|December 16, 1998
Phase I study of a weekly 1 h infusion of paclitaxel in patients with unresectable hepatocellular carcinomaD Strumberg, J Erhard, A Harstrick, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase I study of a weekly schedule of irinotecan, high-dose leucovorin, and infusional fluorouracil as first-line chemotherapy in patients with advanced colorectal cancerU Vanhoefer, A Harstrick, C H Köhne, et al.
Cancer Research|February 24, 2001
D-24851, a novel synthetic microtubule inhibitor, exerts curative antitumoral activity in vivo, shows efficacy toward multidrug-resistant tumor cells, and lacks neurotoxicityG Bacher, B Nickel, P Emig, et al.
Klinische Wochenschrift|August 15, 1980
[Sequential combination chemotherapy with vinblastine/bleomycin and adriamycin/cis-dichlorodiammineplatinum (II) in non-seminomatous testicular cancer. I. Results of a prospective randomized phase III-study with 71 patients with disseminated disease (stage IV) (author's transl)]M E Scheulen, M Higi, R B Schilcher, et al.
Leukemia Research|February 1, 1996
Analysis of the novel cyclin-dependent kinase 4 and 6 inhibitor gene p18 in lymphoma and leukemia cell linesR Siebert, C P Willers, A Fosså, et al.
Human Reproduction (Oxford, England)|November 20, 2004
DNA sequence variations of the entire anti-Mullerian hormone (AMH) gene promoter and AMH protein expression in patients with the Mayer-Rokitanski-Kuster-Hauser syndromeP Oppelt, P L Strissel, A Kellermann, et al.
Cancer Chemotherapy and Pharmacology|June 15, 2000
Investigation of bioavailability and pharmacokinetics of treosulfan capsules in patients with relapsed ovarian cancerR A Hilger, G Jacek, C Oberhoff, et al.
Pageof 26